Zusammenfassung
Während Makrophagen und T- und B-Lymphozyten für die Stimulierung und Regulierung der IgE-spezifischen Immunreaktion verantwortlich sind, fällt die eigentliche Effektorfunktion im akuten allergischen Geschehen der Gewebemastzelle und dem dieser Zelle sehr ähnlichen Blutbasophilen zu. Beide Zellen können innerhalb von Sekunden nach einer spezifischen Stimulierung verschiedene Vermittlersubstanzen freilassen, worauf es lokal oder im gesamten Organismus zu massiven Veränderungen kommt. Durch Einwirken dieser primären Mediatoren können weitere Effektorzellen, hauptsächlich eosinophile und neutrophile Zellen, zu Hilfe gerufen werden und den Ablauf der Entzündungsreaktionen durch Mediatoren und modulierende Substanzen entscheidend verändern. Diese Zellen und die komplexen Vorgänge, die durch sie verursacht werden, sollen hier anhand neuerer Befunde diskutiert werden, um auf diese Weise den klinischen Ablauf der akuten allergischen Reaktion verständlicher werden zu lassen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bach MK, Brashler JR (1978) Ionophore A 23 187 - induced production of slow reacting substance of anaphylaxis (SRS-A) by rat peritoneal cells in vitro: Evidence for production by mononuclear cells. J Immunol 120: 998–1005
Behrendt H, Czarnetzki BM, Seemayer N (1980) Differentiation of mast cells from mononuclear phagocytes. Fed Proc 39: 453
Brocklehurst WE (1960) The release of histamine and formation of a slow reacting substance (SRS-A) during anaphylactic shock. J Physiol (Lond) 151: 416–435
Conroy MC, Orange RP, Lichtenstein LM (1976) Release of slow reacting substance (SRS-A) from human leukocytes by the calcium ionophore A 23187. J Immunol 116: 1677–1681
Czarnetzki BM (1980) Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes. Immunbiology 157: 62–66
Czarnetzki BM (1980) Generation of eosinophil chemotactic factor (ECF) during phagocytosis of macrophages and mast cells. Fed Proc 39: 691
Czarnetzki BM, Zimmermann RE (to be published) Further characterization of the neutrophil-derived eosinophil chemotactic factor (ECF) and comparison to eosinophil chemotactic activity from mast cells. Monogr Allergy
Czarnetzki BM, König W, Lichtenstein LM (1975) Eosinophil chemotactic factor release from human polymorphonuclear neutrophils by calcium ionophore A23 187 and by phagocytosis. Nature 258: 725–726
Czarnetzki BM, König W, Lichtenstein LM (1976) Antigen-induced eosinophil chemotactic factor ( ECF) release by human leukocytes. Inflammation 1: 201–215
Czarnetzki BM, Hannich D, Niedorf H (1980) Generation of mast cells from tissue precursor cells in vitro. Immunbiology 156: 470–476
Czarnetzki BM, Panneck W, Frosch PJ (1980) Inhibitory effect of heparin on leukocyte chemotactic factors. Clin Exp Immunol 39: 526–531
Demopoulos CA, Pinckard RN, Hanahan DJ (1979) Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-snglyceryl-3-phosphorylcholine as the active component ( A new class of lipid chemical mediators ). J Biol Chem 254: 9355–9358
Dessaint JP, Capron A, Joseph M, Bazin H (1979) Cytophilic binding of IgE to the macrophage II. Immunologic release of lysosomal enzyme from macrophage by IgE and anti-IgE in the rat: A new mechanism of macrophage activation. Cell Immunol 46: 24–34
Ehrlich P (1879) Beiträge zur Kenntnis der granulierten Bindegewebszellen and der eosinophilen Leukocyten. Arch Anat Physiol Abt 3: 166–169
Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71: 3400–3404
Henson PM (1970) Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leukocytes and antigen. J Exp Med 131: 287–306
Ishizaka K, Ishizaka T (1967) Identification of E-antibodies as carrier of reaginic activity. J Immunol 99: 1187–1198
Ishizaka K, Ishizaka T (1979) Immunoglobulin E: Biosynthesis and immunological mechanisms of IgE-mediated hypersensitivity. In: Gupta S, Good RA (eds) Cellular, molecular and chemical aspects of allergic disorders. Plenum New York, pp 153–178
Ishizaka T, deBernardo R, Tomioka H, Lichtenstein LM, Ishizaka K (1972) Identification of basophil granulocytes as a site of allergic histamine release. J Immunol 108: 1000–1008
Ishizaka T, Ishizaka K, Tomioka H (1972) Release of histamine and slow reacting substance of anaphylaxis ( SRS-A) by IgE-anti-IgE-reactions on monkey mast cells. J Immunol 108: 513–520
Kay AB, Austen KF (1971) The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol 107: 899–902
Kitamura Y, Shimada M, Hatanaka K, Miyano Y (1977) Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268: 442–443
Lotner GZ, Lynch JM, Betz SJ, Henson PM (1980) Human neutrophil-derived platelet activating factor. J Immunol 124: 676–684
McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN (1980) Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet activating factor ( PAF) in the rabbit. J Immunol 124: 2919–2924
Mencia-Huerta JM, Benveniste J (1979) Platelet-activating factor and macrophages I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol 9: 409–415
Murphy RC, Hammarström S, Samuelsson B (1979) Leukotriene C: A slow reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76: 4275–4279
Padawer J (1971) Phagocytosis of particulate substances by mast cells. Lab Invest 25: 320–330
Plant M, Lichtenstein LM (1978) Histamine, 5-hydroxytryptamine, SRS-A: Discussion of type I hypersensitivity. In: Vane JR, Ferreira SH (eds) Inflammation. Springer, Berlin Heidelberg New York, pp 345–373
Radmark O, Malmsten C, Samuelsson B (1980) Leukotriene A: Stereochemistry and enzymatic conversion to leukotriene B. Biochem Biophys Res Commun 92: 954–961
Riley JF, West GB (1953) The presence of histamine in tissue mast cells. J Physiol 120: 528–537
Samuelsson B, Borgeat P, Hammarström S, Murphy RC (1979) Introduction of a nomenclature of leukotrienes. Prostaglandins 17: 785–787
Sher A, Hein A, Moser G, Caufield JP (1979) Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab Invest 41: 490–499
Tannenbaum S, Oerkel H, Henderson W, Kaliner M (1980) The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J Immunol 125: 325–335
Wassermann SI, Soter NA, Center DM, Austen KF (1977) Cold urticaria: Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 60: 189–196
Yoshida T, Amsden A, Ksiazek J, Cohen S (1978) The effect of heparin on chemotactic and migration inhibitory lymphokines. Clin Immunol Immunopathol 10: 287–291
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Czarnetzki, B.M. (1981). Effektorzellen der anaphylaktischen Reaktion. In: Christophers, E., Goos, M. (eds) XXXII. Tagung gehalten in Westerland/Sylt vom 16. bis 20. September 1980. Verhandlungen der Deutschen Dermatologischen Gesellschaft, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81671-0_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-81671-0_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-10909-9
Online ISBN: 978-3-642-81671-0
eBook Packages: Springer Book Archive